Nozaki, M and Ota, S and Terada, S and Li, Y and Uehara, K and Gharaibeh, B and Fu, FH and Huard, J
(2012)
Timing of the administration of suramin treatment after muscle injury.
Muscle and Nerve, 46 (1).
70 - 79.
ISSN 0148-639X
![[img]](http://d-scholarship.pitt.edu/style/images/fileicons/text_plain.png) |
Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)
|
Abstract
Introduction: It has been reported that suramin treatment can improve muscle healing; however, details about optimizing the dosing requirements remain unclear. The purpose of this study was to determine the optimal timing of suramin administration and investigate the effects it had on the expression of myostatin, follistatin, and muscle vascularity after muscle injury. Methods: Contusion injured muscles of mice were treated with suramin at 1, 2, or 3 weeks post-injury and evaluated histologically and physiologically at 1, 2, and 10 days after injection. Results: Suramin treatment initiated at 2 weeks post-injury was observed to promote muscle regeneration and muscle strength, and to decrease fibrosis. Suramin reduced myostatin expression and increased follistatin expression and vascularity in injured skeletal muscle. Conclusions: Suramin's positive effect on muscle regeneration is thought to be due to its enhancement of follistatin expression which increases neoangiogenesis and inhibits myostatin's promotion of fibrosis. © 2012 Wiley Periodicals, Inc.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
Article
|
| Status: |
Published |
| Creators/Authors: |
|
| Centers: |
Other Centers, Institutes, Offices, or Units > Stem Cell Research Center |
| Date: |
1 July 2012 |
| Date Type: |
Publication |
| Journal or Publication Title: |
Muscle and Nerve |
| Volume: |
46 |
| Number: |
1 |
| Page Range: |
70 - 79 |
| DOI or Unique Handle: |
10.1002/mus.23280 |
| Schools and Programs: |
School of Medicine > Orthopaedic Surgery |
| Refereed: |
Yes |
| ISSN: |
0148-639X |
| MeSH Headings: |
Animals; Antineoplastic Agents--administration & dosage; Antineoplastic Agents--therapeutic use; Contusions--drug therapy; Contusions--metabolism; Drug Administration Schedule; Fibroblasts--drug effects; Fibroblasts--metabolism; Fibrosis--metabolism; Follistatin--metabolism; Male; Mice; Muscle Strength--drug effects; Muscle, Skeletal--drug effects; Muscle, Skeletal--injuries; Muscle, Skeletal--metabolism; Suramin--administration & dosage; Suramin--therapeutic use; Wound Healing--drug effects |
| PubMed ID: |
22644812 |
| Date Deposited: |
31 Mar 2014 15:33 |
| Last Modified: |
25 Jan 2019 23:55 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/20849 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |
![[feed]](/images/feed-icon-32x32.png){kind=icon}